DNA Nanobots, LLC
DNA Nanobots, LLC is a pioneering company founded in 2021 in Columbus, Ohio, originating from Ohio State University. It specializes in developing DNA nanotechnology-based solutions for biomedical applications, including targeted cancer drug delivery, vaccine development, and nucleic acid biosensing. The company's mission is to revolutionize healthcare by creating innovative therapeutic and diagnostic tools using DNA nanotechnology, aiming to improve patient outcomes and advance personalized medicine. With a strong focus on research, development, and collaboration, DNA Nanobots is at the forefront of the DNA nanomedicine space, offering product development services and solutions that harness the programmability and self-assembly properties of DNA to create nanostructures for targeted delivery, gene therapy, vaccines, biosensing, and more.
Industries
Nr. of Employees
small (1-50)
DNA Nanobots, LLC
Products
Programmable DNA nanoparticle delivery platform
A programmable delivery platform based on DNA nanostructures intended to encapsulate or present therapeutic payloads (small molecules, proteins, peptides, nucleic acids) for targeted delivery and controlled release.
DNA-based nucleic acid diagnostic platform (point-of-care)
A diagnostic platform concept using DNA-based sensing for rapid detection of RNA or DNA targets at the point-of-care with minimal equipment.
Programmable DNA nanoparticle delivery platform
A programmable delivery platform based on DNA nanostructures intended to encapsulate or present therapeutic payloads (small molecules, proteins, peptides, nucleic acids) for targeted delivery and controlled release.
DNA-based nucleic acid diagnostic platform (point-of-care)
A diagnostic platform concept using DNA-based sensing for rapid detection of RNA or DNA targets at the point-of-care with minimal equipment.
Services
Collaborative contract research and development to adapt DNA-based delivery systems for external payloads, including conjugation, targeting, and delivery-development workflows.
End-to-end design and engineering service to create custom DNA-based nanostructures for targeted delivery, diagnostic sensors, or research applications.
Collaborative contract research and development to adapt DNA-based delivery systems for external payloads, including conjugation, targeting, and delivery-development workflows.
End-to-end design and engineering service to create custom DNA-based nanostructures for targeted delivery, diagnostic sensors, or research applications.
Expertise Areas
- DNA nanostructure design and DNA origami
- Targeted drug delivery
- Non-viral gene delivery
- Vaccine delivery and APC targeting
Key Technologies
- Programmable DNA origami nanostructures
- Non-viral gene delivery platforms
- DNA-based nanoparticle drug delivery
- Nucleic acid sensing platforms (RNA/DNA)
News & Updates
Presentation of DNA nanobots' latest research in gene delivery at AACR 2024.
Showcasing advancements in targeted drug delivery using DNA nanostructures at AACR 2024.
Analysis of how DNA origami nanobots can enhance ADC technology.
Introduction of MagicDNA 2.0, a platform for advanced DNA nanostructure design.
Overview of gene delivery technologies and the role of DNA nanobots.
An in-depth look at gene delivery challenges and how DNA nanobots can address them.
Presentation of DNA nanobots' latest research in gene delivery at AACR 2024.
Showcasing advancements in targeted drug delivery using DNA nanostructures at AACR 2024.
Analysis of how DNA origami nanobots can enhance ADC technology.
Introduction of MagicDNA 2.0, a platform for advanced DNA nanostructure design.
Overview of gene delivery technologies and the role of DNA nanobots.
An in-depth look at gene delivery challenges and how DNA nanobots can address them.